0001140361-12-035019.txt : 20120803 0001140361-12-035019.hdr.sgml : 20120803 20120803151030 ACCESSION NUMBER: 0001140361-12-035019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120801 FILED AS OF DATE: 20120803 DATE AS OF CHANGE: 20120803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AYERS JONATHAN W CENTRAL INDEX KEY: 0001184149 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 121006617 MAIL ADDRESS: STREET 1: IDEXX LABORATORIES, INC. STREET 2: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 doc1.xml FORM 4 X0306 4 2012-08-01 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001184149 AYERS JONATHAN W ONE IDEXX DRIVE WESTBROOK ME 04092 1 1 0 0 Chairman, President & CEO Common Stock 2012-08-01 4 M 0 20000 0 A 356686 D Common Stock 2012-08-01 4 S 0 14800 88.0564 D 341886 D Common Stock 2012-08-01 4 S 0 200 88.6093 D 341686 D Non-Qualified Stock Option (right to buy) 38.3350 2012-08-01 4 M 0 20000 0 D 2013-02-13 Common Stock 20000 37392 D The sale reported above was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 04/27/2012. The sale price reported reflects the weighted average price of multiple transactions on the reported date at prices that ranged from $87.57 to $88.51, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 to this Form 4. The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $88.58 to $88.63, inclusive. Grant of options to buy shares of common stock becomes exercisable as to 12,000 shares on 02/14/2007, 02/14/2008, 02/14/2009, 02/14/2010, and the remaining 9,392 shares on 02/14/2011. Conan R. Deady, Attorney-in-Fact for Jonathan W. Ayers 2012-08-03